Drug checking services for people who use drugs: a systematic review

Cited by (260)

Items 101–200 of 260

1. Product and trial design considerations on the path towards a vaccine to combat opioid overdose
   Asimenia Angelidou, Jacob A. Koster, Amy C Sherman, Caitlyn McLoughlin, Pooja D. Lalwani, Aisling Kelly, Ahsan Saeed, Kerry McEnaney, Lindsey Robert Baden, Melissa Brogna et al. · 2025 · npj Vaccines
2. Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject Drugs
   Nabila El‐Bassel, STEVEN J. SHOPTAW, Timothy Skalland, Brett S. Hanscom, W. Clarke, Mark A. Marzinke, Jessica M. Fogel, Paul Richardson, Rahul Paul Choudhury, Cécile Denis et al. · 2026 · JAMA Network Open
3. Development of a neural network model to predict the presence of fentanyl in community drug samples
   Lianping Ti, Cameron J Grant, Samuel Tobias, Dennis K. Hore, Richard R. Laing, Brandon D. L. Marshall · 2023 · PLoS ONE
4. Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service
   Hayley Thompson, Karen McDonald · 2023 · International Journal of Environmental Research and Public Health
5. “It would really support the wider harm reduction agenda across the board”: A qualitative study of the potential impacts of drug checking service delivery in Scotland
   Danilo Falzon, Tessa Parkes, Hannah Carver, Wendy Masterton, Bruce B. Wallace, Vicki Craik, Fiona Catherine Measham, Harry R. Sumnall, Rosalind Gittins, Carole Hunter et al. · 2023 · PLoS ONE
6. Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand
   Jai Whelan, Geoff Noller, Ryan D. Ward · 2024 · Harm Reduction Journal
7. The role of on‐site drug analysis within supervised injecting facilities: A case presentation of an adverse event highlighting need
   Robert Page, MARIANNE E. JAUNCEY, Jonathan Brett, Will Wood, Amanda Roxburgh · 2024 · Drug and Alcohol Review
8. Development of a high-resolution paper-spray mass spectrometry method using street drugs for the early detection of emerging drugs in the unregulated supply
   Allie Miskulin, Bruce B. Wallace, Dennis K. Hore, Chris G. Gill · 2025 · The Analyst
9. New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
   Maria Alías-Ferri, Manuela Pellegrini, Emilia Marchei, Roberta Pacifici, Maria Concetta Rotolo, Simona Pichini, Clara Pérez‐Mañá, Esther Papaseit, Roberto Muga, Francina Fonseca et al. · 2022 · Biology
10. Responsibility, Care and Trust Among People Using Drug Checking Services at a Music Festival
    Helena Valente, Monica Jane Barratt, Daniel Martins, Luís Fernandes, Marta Pinto · 2024 · Contemporary Drug Problems
11. Sharing drug checking results in a Canadian setting: a multi-site analysis
    Joshua Bird, Samuel Tobias, Cameron Charles Grant, Mark Lysyshyn, Kenneth W. Tupper, Evan Wood, Thomas H Kerr, Lianping Ti · 2025 · International Journal of Drug Policy
12. Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances
    Merci Ujeneza, Jessica Tardif, Erin Thompson, Adina Badea, Alexis Morales, Cole Jarczyk, Traci Craig Green, Rachel L. Serafinski, Michelle McKenzie, Ju Nyeong Park · 2025 · Drug and Alcohol Review
13. Deadly confusion of novel psychoactive substances: fatal outcome of ADB-BUTINACA mislabeled as 3’,4’-methylenedioxy-α-pyrrolidinohexiophenone
    Annette Zschiesche, Nadine Theofel, Stefan Braukmüller, Edwin Ehrlich, Martin Jasyk, Maximilian Methling, Michael Tsokos, Stefan Scholtis, Laura M. Huppertz, Volker Auwärter · 2025 · Forensic Toxicology
14. Fentanyl Exposure and Detection Strategies Utilized by Clinical Trial Participants Seeking Linkage to Opioid Use Disorder Treatment at a Syringe Service Program
    Dennis P. Watson, Bradley R. Ray, Peter Lee Phalen, Sarah E. Duhart Clarke, Lisa Taylor, James A. Swartz, Nicole Gastala · 2023 · Journal of Medical Toxicology
15. Implementation of a community-based LC-UV drug checking service: promising preliminary findings on feasibility and validity
    Nicolas Fabresse, Eurydice Papias, Alma Heckenroth, Victor Martin, Daniel Allemann, Perrine Roux · 2024 · Harm Reduction Journal
16. Increases in the use of drug testing kits among nightclub and festival attendees in New York City who use ecstasy, 2017–2022
    Nicole D. Fitzgerald, Joseph J. Palamar · 2024 · Drug and Alcohol Review
17. The Psychedelic Social Club: a regulatory concept for people who use psychedelics?
    Henry Harder, Fabian Pitter Steinmetz, Maja Kohek · 2023 · Drugs Education Prevention and Policy
18. Drug testing after use: what insights can be gained from a harm reduction perspective on visitors of the drugs information and monitoring system (DIMS) in the Netherlands?
    Stefania Schiavone, Nadia R. P. W. Hutten, María Bové, Maria Grazia Morgese, Luigia Trabace, Laura Alexandra Smit‐Rigter · 2025 · Harm Reduction Journal
19. A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts
    Jeanette M. Bowles, Manal Mansoor, Dan Werb, Thomas H Kerr, Geoff Bardwell · 2023 · Journal of Substance Use and Addiction Treatment
20. Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine
    Raagini Jawa, Samantha Blakemore, Stephen Murray, Alicia S. Ventura, Tavita Hristova, Alexa Wilder, Margaret Shang, Tehya Johnson, Colleen T. LaBelle · 2024 · Journal of Addiction Medicine
21. Welfare first: transforming harm reduction at UK festivals
    Joseph Janes · 2025 · Harm Reduction Journal
22. Development, Evaluation, and Initial Findings of New York State Department of Health Community Drug Checking Pilot Programs
    Emily R. Payne, Guy J. Thomas, Matthew Fallico, Allan Clear, Maka Gogia, Lucila M. Zamboni · 2024 · Journal of Public Health Management and Practice
23. ‘I will not use it because the results are bad’ – understanding the influence of the drug checking service on changing consumption behavior
    Marko Verdenik, Sara Rolando, Matej Sande · 2024 · Drugs Education Prevention and Policy
24. Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: A validation study
    Hannah Crepeault, Samuel Tobias, Jennifer Angelucci, Stephanie Dubland, Mark Lysyshyn, Evan Wood, Lianping Ti · 2025 · Drug and Alcohol Dependence
25. Psychological and socio-structural determinants of intentions to use drug checking services
    Timothy M. Piatkowski, Kyra Hamilton, Martin S. Hagger · 2025 · Journal of Health Psychology
26. Implementing community drug checking in smaller urban communities: a qualitative study exploring contextual factors to consider
    Abby Hutchison, Karen A. Urbanoski, Dennis K. Hore, Bruce B. Wallace · 2025 · Harm Reduction Journal
27. When pink powders shift the drug landscape: tusi (“pink cocaine”) and other colored powders
    Nicole D. Fitzgerald, Nina Abukahok, Joseph J. Palamar · 2025 · International Journal of Drug Policy
28. Polydrug overdose mortality caused by synthetic opioids and stimulants: current sex- and age-specific trajectories in United States national data for 2018–2024
    Eduardo R. Butelman, Yuefeng Huang, Siri Shastry, Alex F. Manini, Rita Z. Goldstein, Nelly Alia-klein A · 2025 · Neuropsychopharmacology
29. Associations among drug acquisition and use behaviors, psychosocial attributes, and opioid-involved overdoses
    James A. Swartz, Peipei Zhao, Ross Jacobucci, Dennis P. Watson, Mary Ellen Mackesy‐Amiti, Dana Franceschini, Antonio D. Jimenez · 2024 · BMC Public Health
30. Supervised Consumption Services
    Jeanette M. Bowles, Meaghan Thumath, Gillian Kolla, Zoë Dodd, Jaime Arredondo Sanchez Lira, Frank Crichlow, Leo A. Beletsky · 2023 · Oxford University Press eBooks
31. Rapid emergence of UV stabilizer Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate (BTMPS) in the illicit fentanyl supply across the United States in July-August 2024: Results from drug and drug paraphernalia testing
    Chelsea L. Shover, Morgan Godvin, Meghan Grace Appley, Elise M. Pyfrom, Fernando Montero, Karli R. Hochstatter, Talia Nadel, Neil K. Garg, Adam J Koncsol, Joseph R. Friedman et al. · 2024 · medRxiv
32. “Goofballing”: An Emerging Threat With Clinical Challenges
    Guillaume Drevin, Marie B Briet, Séverine Ferec, Chadi Abbara · 2025 · Therapeutic Drug Monitoring
33. ‘It'd Be Nice to Know if You're About to Have Drain Cleaner’: A Qualitative Study of Preferred Drug Checking Service Features to Inform the Design of CheQpoint , Queensland's First Fixed‐Site Drug Checking Service
    Cheneal Puljević, Nina Pocuca, Brodie C. Dakin, Monica Jane Barratt, Cameron Francis, Daniel Stjepanović, Sara Gill, Geoff Davey, Leanne M. Hides · 2025 · Drug and Alcohol Review
34. Navigating US illicit drug market volatility: harm reduction strategies employed by people who inject drugs
    Abigail K. Winiker, Laura Nicole Sisson, Kristin E. Schneider, Saba Rouhani, Emily M. Martin, Danielle Friedman Nestadt, Bradley E. Silberzahn, Leanne Zhang, Katherine H. A. Footer, Susan G. Sherman · 2025 · Health Promotion International
35. ‘I Wanna Know What I'm Putting in My Body’ : Perceptions of Drug Checking Services and Supply Information Among People Who Use Drugs in Rhode Island
    Katherine T. Dunham, E. Claire Macon, Raynald Joseph, Rachel Wightman, Alexandra B. Collins · 2025 · Drug and Alcohol Review
36. Possible effects of cheap fentanyl on drug markets, use, and harm: A theoretical analysis
    Jonathan P. Caulkins, Shawn David Bushway, H. Brinton Milward, Peter H. Reuter · 2025 · Global Crime
37. From trash to results: shortcomings and benefits of paraphernalia-based drug checking in Finland
    Teemu Kaskela, Janne Nahkuri, Aino Kankaanpää, Anna Pelander, Teemu Gunnar, J. Tuomas Harviainen, Jouni Tourunen · 2025 · Harm Reduction Journal
38. Trends in recurrent overdose and treatment initiation following emergency department visits for opioid overdose between 2016 and 2021
    Tenzin Yangchen, McClaren Rodríguez, Janette B. Baird, Benjamin D. Hallowell, Mackenzie M. Daly, Justin Berk, Rachel Gaither, Rachel Wightman, Francesca L. Beaudoin, Laura C. Chambers · 2024 · Drug and Alcohol Dependence
39. Die Herausforderungen für die psychiatrische Versorgung durch synthetische Drogen
    Norbert Scherbaum, Udo Bonnet · 2024 · Der Nervenarzt
40. A rapid scoping review of harm reduction strategies for ecstasy (MDMA) users in recreational settings
    Deborah J. Edwards, Judit Katalin Csontos, Michael J Pascoe, Andrew D. Westwell, Elizabeth Gillen, Clare Louise Bennett, Ben Hannigan, Judith Carrier, Jane Harden · 2022 · Research Square
41. A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand
    Jai Whelan, Ryan D. Ward, Geoff Noller · 2024 · Harm Reduction Journal
42. The Glasgow drug consumption room: A job half done?
    Phil Dalgarno, Steve O’Rawe · 2024 · Drug Science Policy and Law
43. Substance Checking Outreach and PrEP Engagement (SCOPE) Study: protocol for a non-randomised clinical trial in Baltimore, Maryland USA
    Kristin E. Schneider, Danielle Friedman Nestadt, Emily M. Martin, Miles Morris, Saba Rouhani, Brian W. Weir, Susan G. Sherman · 2025 · BMJ Open
44. An implementation science study of a campus-based drug checking service at a Canadian university
    Lauren Airth, Bruce Wallace, Mary Clare Kennedy, Lucas Standing, Antoine Marcheterre, Lianping Ti, Jennifer Matthews, Melissa Feddersen, Nelly D. Oelke · 2025 · PLoS ONE
45. Harm reduction approaches for the use of benzodiazepines: a scoping review
    Caity Morrison, Isabella Natale, Antigone Branchflower, Craig Harvey, Robert M. Lundin · 2025 · Harm Reduction Journal
46. Repeated‐dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A two‐site phase III randomized controlled trial
    Phillip Oliver Coffin, Glenn‐Milo Santos, Vanessa McMahan, Xochitl Luna Marti, Tim Matheson, Sarah Brennan, Justine Arenander, Mackenzie Robinson, John Farley, Emily Pope et al. · 2025 · Addiction
47. Piloting a Point-of-Care Drug-Checking Service at Syringe Service Programs in New York City
    Yarelix Estrada, Hannah L. Helmy, Ashly E. Jordan, Andrew J. Trinidad, Leonardo Dominguez Gomez, Izza Zaidi, Jeffery Sauer, Alex Harocopos · 2025 · Substance Use &amp Addiction Journal
48. Exploring drug checking services for people who use drugs: Pre-implementation study
    Whitney Ludwig, Kaitlyn Jaffe, Steve Alsum, Mary Dwan, Robert J. Ploutz-Snyder, Clayton J. Shuman, Chin Hwa Dahlem · 2025 · Drug and Alcohol Dependence
49. Real time, on-site drug checking in low-threshold housing communities
    Charlie Summers, Joseph Silcox, Sofia Zaragoza, Sabrina S. Rapisarda, Abigail Edelmann, Avik Chatterjee, Traci Craig Green · 2026 · Harm Reduction Journal
50. Drug checking services: barriers and facilitators to implementation by U.S. syringe services programs
    Jessica Smith, Sarah M. Philbrick, Christopher F. Akiba, Lynn D. Wenger, Sara Hairgrove, Alex H. Kral, Barrot H. Lambdin, Sheila Vipul Patel · 2026 · Harm Reduction Journal
51. Exploring Risk Prevention and Harm Reduction Behaviours among Snorted Cocaine Users
    Carolina Pinzón Gómez, Miguel B Cruz-Lopez, Maria Paula Gamboa Bayona, Carlos Hernán Gantiva Quintero · 2024 · Revista Internacional de Investigación en Adicciones
52. Substance Use Monitoring Among People Who Use Drugs Using a Novel Assay to Test Dried Blood Spot Specimens
    Kaitlin A. Zinsli, Alex J. Krotulski, Melissa F. Fogarty, Devin Kress, Barry Kerr Logan, Anthony R. Morgan, Jeremy M. Beckford, Brandon L. Guthrie, Judith I. Tsui, Don C. Des Jarlais et al. · 2025 · Substance Use & Misuse
53. Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study
    Pierre-Julien Coulaud, Koharu Loulou Chayama, Cameron Schwartz, Aaron Purdie, Mark Lysyshyn, Lianping Ti, Rod Knight · 2024 · Harm Reduction Journal
54. L’analyse des drogues comme outil de réduction des risques : méthodes, enjeux et perspectives
    Eurydice Papias, Perrine Roux, Anne‐Laure Pélissier‐Alicot, Nicolas Fabresse · 2025 · Annales de Toxicologie Analytique
55. Young sexual and gender minority men’s perspectives on drug checking services in Metro Vancouver, Canada: a qualitative study
    Koharu Loulou Chayama, Pierre-Julien Coulaud, Cameron Schwartz, Olivier Ferlatte, Lianping Ti, Rod Knight · 2025 · The American Journal of Drug and Alcohol Abuse
56. Home Cultivation of Cannabis in a Context of Prohibition: Results from Two Online Cross-Sectional Surveys of People Using Cannabis Daily in France
    Martin Bastien, Salim Mezaache, Cécile Donadille, Laélia Briand Madrid, Maëla Lebrun, Victor Martin, Perrine Roux · 2025 · International Journal of Environmental Research and Public Health
57. Fentanyl concentrations in unregulated opioids and the blood of drug toxicity decedents
    Samuel Tobias, Andrew W. Tu, Aaron M. Shapiro, Sandrine A. M. Mérette, Mark Lysyshyn, Evan Wood, Jane A. Buxton, Lianping Ti · 2025 · AJE Advances Research in Epidemiology
58. South African harm reduction guideline for chemsex
    Andrew P. Scheibe, Yolaan Andrews, Benjamin Brown, Naeem Cassim, Thato Chidarikire, Jannie Hugo, Regina Maithufi, Sive Mjindi, Dawie Nel, Shaun Shelly et al. · 2025 · Southern African Journal of HIV Medicine
59. Motivational interviewing to increase drug checking and reduce overdose rates among people who use drugs: protocol for a hybrid type 1 effectiveness–implementation trial of an adjunctive intervention
    Katie Bailey, Steffanie A. Strathdee, Angela R. Bazzi, Tara Stamos-Buesig, Morgan Godvin, Alicia Vera, Daniela A. Abramovitz, Carlos F. Vera, Thomas L. Patterson, Peter J. Davidson et al. · 2025 · BMC Public Health
60. The Housing Instability Scale: Determining a Cutoff Score and Its Utility for Contextualizing Health Outcomes in People Who Use Drugs
    Fawaz Shanun, Daniel Jackson Smith, Beatrice King, Lydia Vlachou, Roesheen McGilvery, Stella Zine, Hayden Henderson, Emily Reichman, Nadiah Cunningham, Morgan Zare et al. · 2025 · International Journal of Environmental Research and Public Health
61. Neue Psychoaktive Substanzen: Rausch und Risiko oft unkalkulierbar
    Udo Bonnet, Norbert Scherbaum · 2025 · PSYCH up2date
62. A descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six states
    Zongbo Li, Tanvi V Chiddawar, Leah C. Shaw, Ashleigh Dennis, Amy Judd Lieberman, Alexandra Kingsepp, Andrew J. Trinidad, Ellenie D. Tuazon, Alice E. Welch, Avik Chatterjee et al. · 2025 · International Journal of Drug Policy
63. Higher levels of naloxone protection are associated with lower risk-taking: A longitudinal analysis of New York City residents using unprescribed opioids
    Luther C. Elliott, Adrian Harris, Dev J. Crasta, Melody S. Goodman, Yuyu Chen, Saba Rouhani, David Frank, Jemar R. Bather, Alex S. Bennett · 2025 · Drug and Alcohol Dependence
64. Synthetic cannabinoids in Mayotte over a year in time and space: an example of high-frequency evolution of market
    Damien Alain Devault, Loïc Fabien, Alexandr Gish, Camille Richeval, Jean‐Michel Gaulier, Thomas Néfau · 2025 · Environmental Science and Pollution Research
65. Support Vector Machine Classification of Adulterated Illicit Opioids Using Paper-Spray Mass Spectrometry
    Allie Miskulin, Bruce B. Wallace, Chris G. Gill, Dennis K. Hore · 2025 · Analytical Chemistry
66. ‘I want to know what I’m taking’—long-term evaluation of the drug checking service in Slovenia and its integration into drug policy
    Marko Verdenik, Ines Kvaternik, Jože Hren, Matej Sande · 2026 · Drugs Education Prevention and Policy
67. A cost–benefit analysis of the implementation and scale‐up of harm reduction interventions in the Australian Capital Territory
    Anna L. Bowring, Tom Tidhar, Anna Olsen, Christopher R. Bailie, Kelvin Burke, Rowan Martin‐Hughes, Helen Keane, Paul Dietze, Nick Scott · 2026 · Addiction
68. Sociodemographic Characteristics and Drug Use Practices Associated with Fentanyl Use Frequency Among People Who Use Drugs in Rhode Island
    Evelyn Lai, Katie B. Biello, Jane A. Buxton, Scott Evan Hadland, Susan G. Sherman, Jacqueline A. Goldman, Julia E. Noguchi, Brandon D. L. Marshall, Alexandria Macmadu · 2026 · Substance Use & Misuse
69. Comparison of anticipated and detected drug contents in samples submitted to a statewide drug checking program in Maryland, USA
    Emily M. Martin, Kristin E. Schneider, Edward Sisco, Meghan Grace Appley, Elise M. Pyfrom, Margaret M. Rybak, Susan G. Sherman · 2026 · Drug and Alcohol Dependence
70. Risk reduction behaviours following the detection of unexpected drugs through community drug checking: a cross-sectional study
    Samuel Tobias, Cameron Grant, Mark Lysyshyn, Perrine Roux, Evan Wood, Thomas H Kerr, Lianping Ti · 2026 · Harm Reduction Journal
71. Impact of lab-based drug checking services on syringe service program engagement in Maryland, USA
    Caitlin M. Berry, David Newton, Margaret M. Rybak, Gregory Malik Burnett, Marcela Najarro, Edward Sisco, Jasmine Lopes, Dennis D. Leber · 2026 · Harm Reduction Journal
72. Attitudes to Drug Policy in Australia, 2001–2022/23: What Does This Mean for Drug Policy Reform in Australia?
    Zachary Lloyd, Amanda Roxburgh · 2026 · Drug and Alcohol Review
73. The use of drug checking legislation to facilitate illicit drug consumption research: psychedelic microdosing as a case example
    Estelle Miller, David Menkes, Suresh D Muthukumaraswamy, Geoff Noller, Rhys Ponton · 2026 · Drugs Habits and Social Policy
74. Safe beats down under: investigating the support of drug checking at a regional festival in the Northern Territory, Australia
    Felicity Wardle, Timothy M. Piatkowski, Sarah Clifford, Amy Peacock, Paul Dietze, Megan S. C. Lim, Caitlin H. Douglass, Penny Hill, Samuel Moore, Mia Miller et al. · 2024 · Drugs Education Prevention and Policy
75. Patterns of opioid toxicity deaths after the implementation of COVID-19 emergency measures in Ontario, Canada: a weekly interrupted time series
    Valeria Rolle, Nicholas Bakewell, Yingbo Na, Mohammad Karamouzian, Orville Burke, Seff Pinch, Dan Werb, Sanjana Mitra · 2025 · International Journal of Drug Policy
76. Do We Need On‐Site Drug Analysis Within Supervised Injecting Facilities?
    Paul A. Calle · 2025 · Drug and Alcohol Review
77. Drug decriminalization, the introduction of fentanyl to drug markets, and fatal overdose in Oregon
    Michael James Zoorob, Ju Nyeong Park, Alex H. Kral, Barrot H. Lambdin, Brandon del Pozo · 2024 · medRxiv
78. Varying drug policies and unequal access to harm reduction
    Julie Holeksa · 2024
79. Associations among Drug Acquisition and Use Behaviors, Psychosocial Attributes, and Opioid-Involved Overdoses: A SEM Analysis
    James A. Swartz, Peipei Zhao, Ross Jacobucci, Dennis P. Watson, Mary Ellen Mackesy-Amiti, Dana Franceschini, A. David Jimenez · 2024 · Research Square
80. Identifying new psychoactive substances (NPS) using drug checking services: An innovative observational study design
    Marc Grifell, Guillem Mir, Roger Estelrich-Azubide, Mireia Ventura, Liliana Galindo, Josep Guilanyà, I. Fornís, Cristina Gil, Maria Roldán, Xoán Carbón et al. · 2022 · Research Square
81. Guest editorial
    Raoul Pieter Joost Koning, Nicolas Van der Linden, Daan van der Gouwe, Mireia Ventura, Fiona Catherine Measham · 2022 · Drugs Habits and Social Policy
82. A rapid scoping review of self-initiated harm reduction strategies for ecstasy (MDMA) users in recreational settings
    Deborah J. Edwards, Judit Katalin Csontos, Michael J Pascoe, Andrew D. Westwell, Elizabeth Gillen, Clare Louise Bennett, Ben Hannigan, Judith Carrier, Jane Harden · 2023 · Research Square
83. A rapid scoping review of harm reduction strategies for ecstasy (MDMA) users in recreational settings
    Deborah J. Edwards, Judit Katalin Csontos, Michael J Pascoe, Andrew D. Westwell, Elizabeth Gillen, Clare Louise Bennett, Ben Hannigan, Judith Carrier, Jane Harden · 2024 · Research Square
84. Xylazine Awareness, Desire, Use and Exposure: Preliminary Findings from the Rhode Island CUTS Drug Checking Cohort
    Ju Nyeong Park, Rachel L. Serafinski, Merci Ujeneza, Michelle McKenzie, Jessica Tardif, Alex J. Krotulski, Adina Badea, Elyse R. Grossman, Traci Craig Green · 2024 · medRxiv
85. “I knew where help was.” Identifying Substance Use Patterns, Associated Predictors of Harm, and Barriers to Help Seeking among Music Festival Attendees: The Development of a Targeted Harm Reduction Intervention
    Chloe L. Rayner · 2024
86. 7. Fentanyl Is Everywhere: The Role of Drug Checking to Reduce Overdose Risk
    Bina Ali, Nicholas C. Peiper · 2024 · American Public Health Association eBooks
87. Exploring Community Perceptions of Addiction and Harm Reduction Strategies in Aotearoa New Zealand
    Mia McCulloch · 2024
88. Drogentests
    Simon Egbert · 2024 · Springer eBooks
89. :Opium’s Orphans: The 200-Year History of the War on Drugs
    Frank Hughes · 2024 · The Social History of Alcohol and Drugs
90. Halluzinogene
    Tomislav Majić, Euphrosyne Gouzoulis‐Mayfrank, Michael Schaub · 2024 · Elsevier eBooks
91. Soziologie der Sucht
    Sandro Cattacin · 2024 · Elsevier eBooks
92. A Safer Way to Recovery Amidst the Toxic Drug Crisis
    Sheri Klassen · 2024 · International Journal of Mental Health and Addiction
93. “All it's gonna tell you is if it has fentanyl or not:” Perceptions of fentanyl and drug checking among first responders and people who use drugs
    Brenda Y. Goh, Emily C. Williams, Courteney Wettemann, Callan Elswick Fockele, Tessa M. Frohe, Grover Williams, Nathan Holland, Rachel Rourke, Rob Pitcher, Thea Oliphant-Wells et al. · 2025 · Journal of Substance Use and Addiction Treatment
94. The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders
    Martine Skumlien, Sam Craft, Luke Russell, Navyaa Toshniwal, Christopher R. Pudney, Tom P. Freeman, Jenny Scott · 2025 · Harm Reduction Journal
95. Willingness to use a drug checking service for cannabis and cannabis-based products: results from an online survey of people who regularly use cannabis in France
    Martin Bastien, Salim Mezaache, Cécile Donadille, Laélia Briand Madrid, Maëla Lebrun, Victor Martin, Perrine Roux · 2025 · Harm Reduction Journal
96. Stroke and spinal cord injury induced by psychoactive substance use in drug addiction: A systematic literature review
    Diana Sá Moreira, Celina Pereira, Marta Cruz, Paulo C. Dias, Ângela Maria Teixeira Leite · 2025 · African journal of rhetoric
97. Relative importance of socioecological domains to predicting opioid-involved mortality
    Joshua Curtis Black, Annika M. Czizik · 2025 · PLoS ONE
98. Scaling up community drug-checking services in B.C. could help respond to the overdose crisis
    Piotr Burek, Bruce Wallace, Dennis K. Hore · 2023
99. Reluctant risk-takers: how law enforcement practices at festivals can obstruct safer drug use
    Dara Ruane · 2025 · International Journal of Drug Policy
100. “We knew it was coming: we didn’t act” perspectives from people who use drugs and substance use workforce on the impact of delays in implementation of the supervised injection facility and drug checking interventions
     Margaret R. Hester, Jaclyn M. W. Hughto, Divya Ravikumar-Grant, Saoirse Nic Gabhainn · 2025 · Harm Reduction Journal